Affiliation:
1. Department of Pathophysiology, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Russian Federation
Abstract
The spread of a new strain of coronavirus, SARS-CoV-2, a pandemic, poses a serious health problem
for all humanity. Compared with the previous outbreaks of coronavirus infection in 2002 and 2012, COVID-19
infection has high rates of lethality, contagiousness, and comorbidity. The effective methods of prevention and
treatment are extremely limited. Oxidative stress is actively involved in the mechanisms of initiation and
maintenance of violations of homeostatic reactions in respiratory viral infections. It is important to stop systemic
inflammation aimed at "extinguishing" the cytokine "storm", caused by the production of reactive oxygen species.
Antioxidant defense medications, such as vitamin C, N-acetylcysteine, melatonin, quercetin, glutathione,
astaxanthin, polyphenols, fat-soluble vitamins, and polyunsaturated fatty acids have proven well in experimental
and clinical studies of influenza, pneumonia, and other respiratory disorders. The use of medications
with antioxidant activity could be justified and most probably would increase the effectiveness of the fight
against new coronavirus.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献